(Q61907707)
Statements
Investigation of Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Multiple Dosing of NNC0174-0833 in Combination With Semaglutide in Subjects Being Overweight or With Obesity (English)
0 references
25 July 2018
0 references
22 January 2020
0 references
80
0 references
18 year
0 references
55 year
0 references